Contineum Therapeutics CTNM
NASDAQ CTNM
$12.87 +1.37 (+11.91%)
As of: Sep 30, 2026 · 1:52 PM EDT

Contineum Therapeutics, Inc. (CTNM) Net Cash Flow (2023 - 2026)

Updated

Contineum Therapeutics (CTNM) posted Net Cash Flow of -$5.45 million for Q2 2026, compared with -$1.69 million a year earlier.

Analysis

Contineum Therapeutics, Inc. (CTNM) Net Cash Flow (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Cash Flow at Contineum Therapeutics was -$6.07 million; for FY2025, it was $53.66 million, up 736.2% from FY2024.

  • In prior years, Contineum Therapeutics' Net Cash Flow was $6.42 million in FY2024 (-35.6%) and $9.96 million in FY2023.
  • Quarterly Net Cash Flow has run from a low of -$55.45 million in Q1 2026 to a high of $60.97 million in Q2 2024 over five years.
  • According to Business Quant data, Net Cash Flow for the three prior quarters was -$55.45 million (Q1 2026), $32.97 million (Q4 2025) and $21.85 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.45 Mn
Mar 31, 2026 -55.45 Mn
Dec 31, 2025 32.97 Mn
Sep 30, 2025 21.85 Mn
Jun 30, 2025 -1.69 Mn
Mar 31, 2025 527,000.00
Dec 31, 2024 -18.95 Mn
Sep 30, 2024 -36.34 Mn
Jun 30, 2024 60.97 Mn
Mar 31, 2024 738,000.00
Dec 31, 2023 -2.00 Mn
Sep 30, 2023 -34.55 Mn
Jun 30, 2023 43.01 Mn
Mar 31, 2023 3.49 Mn
API Access

Contineum Therapeutics, Inc. Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CTNM&period=max&api_key=YOUR_API_KEY